Celldex Therapeutics
CLDX
CLDX
76 hedge funds and large institutions have $365M invested in Celldex Therapeutics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
69% more funds holding
Funds holding: 45 → 76 (+31)
54.61% more ownership
Funds ownership: 22.58% → 77.19% (+55%)
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
Holders
76
Holding in Top 10
5
Calls
$13.2M
Puts
$4.61M
Top Buyers
| 1 | +$35.6M | |
| 2 | +$33.9M | |
| 3 | +$26M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$26M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$22.8M |
Top Sellers
| 1 | -$2.91M | |
| 2 | -$918K | |
| 3 | -$681K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$509K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$251K |